Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.

PHASE2CompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

February 1, 2013

Primary Completion Date

May 20, 2014

Study Completion Date

December 14, 2016

Conditions
Crohn's Disease
Interventions
DRUG

MEDI2070

1 iv infusion on Week 0 and Week 4

DRUG

placebo

1 iv infusion on Week 0 and Week 4

Trial Locations (80)

133

Research Site, Roma

196

Research Site, Roma

1062

Research Site, Budapest

1081

Research Site, Budapest

1125

Research Site, Budapest

7400

Research Site, Kaposvár

8025

Research Site, Barcelona

8035

Research Site, Barcelona

8208

Research Site, Sabadell(Barcelona)

8907

Research Site, L'Hospitalet de Llobregat

8916

Research Site, Barcelona

9700

Research Site, Szombathely

10021

Research Site, New York

10029

Research Site, New York

14482

Research Site, Potsdam

20089

Research Site, Rozzano

20100

Research Site, Milan

20246

Research Site, Hamburg

20249

Research Site, Hamburg

20815

Research Site, Chevy Chase

21201

Research Site, Baltimore

28207

Research Site, Charlotte

28801

Research Site, Asheville

31059

Research Site, Toulouse

31201

Research Site, Macon

32256

Research Site, Jacksonville

32789

Research Site, Winter Park

33136

Research Site, Miami

33604

Research Site, Pessac

38138

Research Site, Germantown

40138

Research Site, Bologna

41014

Research Site, Seville

41071

Research Site, Seville

45219

Research Site, Cincinnati

45242

Research Site, Los Angeles

45806

Research Site, Lima

46026

Research Site, Valencia

48098

Research Site, Troy

48109

Research Site, Ann Arbor

50141

Research Site, Florence

60637

Research Site, Chicago

64012

Research Site, Belton

70403

Research Site, Hammond

70809

Research Site, Baton Rouge

78229

Research Site, San Antonio

80131

Research Site, Napoli

80215

Research Site, Lakewood

80331

Research Site, München

88054

Research Site, Amiens

90505

Research Site, Torrance

92024

Research Site, Encinitas

92114

Research Site, San Diego

92210

Research Site, Clichy

98195

Research Site, Seattle

T6G 2X8

Research Site, Edmonton

V6Z 2K5

Research Site, Vancouver

A1B 3V6

Research Site, St. John's

N1H 3R3

Research Site, Guelph

K7L 5G2

Research Site, Kingston

N6A 5A5

Research Site, London

K1H 8L6

Research Site, Ottawa

M5G 1X5

Research Site, Toronto

M6H 3M1

Research Site, Toronto

L4L 4Y7

Research Site, Vaughan

H3A 1A1

Research Site, Montreal

370 01

Research Site, České Budějovice

500 12

Research Site, Hradec Králové

412 01

Research Site, Litoměřice

708 53

Research Site, Ostrava-Poruba

100 34

Research Site, Prague

170 04

Research Site, Prague

F-76031 CE

Research Site, Rouen

85-168

Research Site, Bydgoszcz

85-681

Research Site, Bydgoszcz

45-061

Research Site, Opole

35-301

Research Site, Rzeszów

81-756

Research Site, Sopot

Unknown

Research Site, Sosnowiec

02-507

Research Site, Warsaw

53-333

Research Site, Wroclaw

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

MedImmune Ltd

INDUSTRY

lead

AstraZeneca

INDUSTRY